Thrombosis and Haemostasis

Article	Citations
Rupatadine Treatment Is Associated with Atherosclerosis Worsening and Altered T Lymphocyte Recruitment	262
Molecular Characterization of Two Homozygous Factor VII Variants Associated with Intracranial Bleeding	235
	127
Heterogeneity in American and European Peripheral Artery Disease Guidelines on Non-statin Lipid-Lowering Therapy and Rivaroxaban	80
Discontinuation of anticoagulants and occurrence of bleeding and thromboembolic events in vitamin K antagonist users with a life-limiting disease	61
	58
Prognostic Significance of Concomitant Superficial Vein Thrombosis in Patients with Deep Vein Thrombosis of the Lower Limbs	57
Home Treatment Compared to Initial Hospitalization in Normotensive Patients with Acute Pulmonary Embolism in the Netherlands: A Cost Analysis	57
Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID Trial	50
Anticoagulant Treatment of COVID-19 as Early as Possible—Sulodexide and Perspectives	50
Protocatechuic Acid Protects Platelets from Apoptosis via Inhibiting Oxidative Stress-Mediated PI3K/Akt/GSK3β Signaling	44
Quantitative 2D 1H, 13C HSQC NMR Spectroscopy for the Determination of Chondroitin Sulfate and Dermatan Sulfate Content in Danaparoid Sodium	40
Stability of Rivaroxaban and Apixaban Anti-Xa Activities in Whole Blood Samples: A French Bicentric Study	37
Of Mice and Man: The Unwinding of CLEC-2 as an Antithrombotic Target?	35
The Optimal Management for People with Acute Stroke and Minor Deficits: Intravenous Thrombolysis or Medical Management?	33
Atherosclerotic Plaque VASA Vasorum in Diabetic Macroangiopathy: WHEN IS Important, but also HOW IS Needed	33
Characterization of the Role of Integrin α5β1 in Platelet Function, Hemostasis, and Experimental Thrombosis	31
Impact of Transcatheter Aortic Valve Implantation on Thrombin Generation and Platelet Function	30
Antithrombin Resistance Rescues Clotting Defect of Homozygous Prothrombin-Y510N Dysprothrombinemia	30
A Systematic Review of Anticoagulation Strategies for Patients with Atrial Fibrillation in Critical Care	30
Characterization of the Platelet Phenotype Caused by a Germline RUNX1 Variant in a CRISPR/Cas9-Generated Murine Model	27
The Asialoglycoprotein Receptor Minor Subunit Gene Contributes to Pharmacokinetics of Factor VIII Concentrates in Hemophilia A	26
Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study	26
Effectiveness and Safety of Apixaban versus Rivaroxaban in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus	25
Response: Does Fibrinolytic Strategy of Pulmonary Embolism International ThrOmbolysis (PEITHO)-3 Trial Need More Strong Evidence?	24

Platelet P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention: An Emerging Option for Antiplatelet Therapy De-escalation	23
	23
Thrombosis and Thrombocytopenia Syndrome Causing Isolated Symptomatic Carotid Occlusion after Covid-19 Vaccine	23
Blood Coagulation and Beyond: Position Paper from the Fourth Maastricht Consensus Conference on Thrombosis	22
	22
Mortality of Escalation and Modulation Antithrombotic Therapy in Coronary Artery Disease Patients: A Meta-analysis of Randomized Controlled Trials	22
The Interaction Effect between Comorbidity Burden and Venous Thromboembolism on Mortality: A Nationwide Cohort Study	21
Plasma Homocysteine in Behcet's Disease: A Systematic Review and Meta-Analysis	21
Comparison of Risk of Serious Cardiovascular Events after Hemorrhagic versus Ischemic Stroke: A Population-Based Study	20
“Novel Clinical Concepts in Thrombosis”: Integrated Care for Stroke Management—Easy as ABC	20
Predictive Modeling Identifies Total Bleeds at 12-Weeks Postswitch to N8-GP Prophylaxis as a Predictor of Treatment Response	20
Risk Factors for Postdischarge Major Thromboembolism and Mortality in Hospitalized Patients with COVID-19 with Cardiovascular Comorbidities: Insights from the CORE-19 Registry	19
Continuous Infusion of Factor VIII and von Willebrand Factor in Surgery: Trials with pdFVIII LFB or pdVWF LFB in Patients with Bleeding Disorders	19
Tyrosine Kinase Inhibitor Sunitinib Delays Platelet-Induced Coagulation: Additive Effects of Aspirin	18
Does Fibrinolytic Strategy of Pulmonary Embolism International THrOmbolysis (PEITHO)-3 Trial Need More Strong Evidence?	18
Anticoagulant Effects of Dabigatran on Coagulation Laboratory Parameters in Pediatric Patients: Combined Data from Five Pediatric Clinical Trials	18
The PAR4 Platelet Thrombin Receptor Variant rs773902 does not Impact the Incidence of Thrombotic or Bleeding Events in a Healthy Older Population	17
Comparison of Bleeding Risk Scores in Elderly Patients Receiving Extended Anticoagulation with Vitamin K Antagonists for Venous Thromboembolism	17
Hematopoiesis of Indeterminate Potential and Atherothrombotic Risk	17
miR-204-5p and Platelet Function Regulation: Insight into a Mechanism Mediated by CDC42 and GPIIbIIIa	17
Protocol for a Systematic Review and Individual Participant Data Meta-Analysis of Randomized Trials of Screening for Atrial Fibrillation to Prevent Stroke	16
Oral Anticoagulant Use in Patients with Morbid Obesity: A Systematic Review and Meta-Analysis	16
DOAC Dipstick Testing Can Reliably Exclude the Presence of Clinically Relevant DOAC Concentrations in Circulation	16
MicroRNAs as Biomarkers for Personalized Antiplatelet Therapy	16
Knockdown and Knockout of Tissue Factor Pathway Inhibitor in Zebrafish	16
F11 Gene Duplication Causes Elevated FXI Plasma Levels and Is a Risk for Venous Thrombosis	16
Significant Major Bleeding in Hospitalized Patients with COVID-19 Receiving Thromboprophylaxis	15
Newborn and Pediatric Reference Intervals for Coagulation Assays Using Novel Reagents	15
Visualization of Domain- and Concentration-Dependent Impact of Thrombomodulin on Differential Regulation of Coagulation and Fibrinolysis	15
Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-Paclitaxel	15
Roles of ROCK/Myosin Pathway in Macrothrombocytopenia in Bernard–Soulier Syndrome	14
Machine Learning to Predict Outcomes in Patients with Acute Pulmonary Embolism Who Prematurely Discontinued Anticoagulant Therapy	14
Prevalence of Bleeding and Thrombosis in Critically Ill Patients with Chronic Liver Disease	14
Incidence of Pregnancy-Associated Venous Thromboembolism: Second Nationwide Study	14
High-Dose Epinephrine Enhances Platelet Aggregation at the Expense of Procoagulant Activity	14
2021 Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulants	14
The ADA (Age-D-Dimer-Albumin) Score to Predict Thrombosis in SARS-CoV-2	14
Protective Role of Activated Protein C against Viral Mimetic Poly(I:C)-Induced Inflammation	14
The Association between Obstructive Sleep Apnea and Venous Thromboembolism: A Bidirectional Two-Sample Mendelian Randomization Study	14
Long-Term Risk of Major Bleeding after Discontinuing Anticoagulation for Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis	14
Relationship Between Screening-Detected Atrial Fibrillation and Blood Pressure Levels in Elderly Hypertensive Patients: The OMRON Heart Study	14
Apixaban and Dalteparin for the Treatment of Venous Thromboembolism in Patients with Different Sites of Cancer	14
Compromised PAR1 Activation—A Cause for Bleeding in XMEN?	14
Whole Blood Viscosity and Thromboembolic Events in Hospitalized Patients with COVID-19: Post hoc Analysis of the ATTACC/ACTIV-4a Trial	14
Shear Stress Promotes Remodeling of Platelet Glycosylation via Upregulation of Platelet Glycosidase Activity: One More Thing	13
A Phase 1b PK/PD Study to Demonstrate Antigen Elimination with RLYB212, a Monoclonal Anti-HPA-1a Antibody for FNAIT Prevention	13
Non-vitamin K Antagonist Oral Anticoagulant, Warfarin, and ABC Pathway Adherence on Hierarchical Outcomes: Win Ratio Analysis of the COOL-AF Registry	13
Exploring Causal Relationships between Circulating Inflammatory Proteins and Thromboangiitis Obliterans: A Mendelian Randomization Study	13
Atherosclerotic Autoantigen ALDH4A1 as a Novel Immunological Indicator for Plaque Erosion in Patients with ST Segment Elevated Myocardial Infarction	13
The Effect of Cytokine Adsorption on Leukocyte and Platelet Activation after Extracorporeal Cardiopulmonary Resuscitation	13

Guided Anti-P2Y12 Therapy in Patients Undergoing Percutaneous Coronary Intervention	13
Not Just CTEPH: A Narrative Review on the Spectrum Approach to Postpulmonary Embolism Conditions	12
A Systematic Review of Efficacy and Safety of Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Voncento) in von Willebrand Disease	12
Genotype-Dependent Response to Desmopressin in Hemophilia A and Proposal of a Predictive Response Score	12
Proteomic Characterization of Plasma in Lemierre's Syndrome	12
Binding Promiscuity of Therapeutic Factor VIII	12
Persistent and Late-Onset Disseminated Intravascular Coagulation Are Closely Related to Poor Prognosis in Patients with Sepsis	12
Predicting Bleeding in Cancer-Associated Venous Thromboembolism: Another Milestone Achieved	12
	12
Unraveling the Molecular Pathogenesis of Protein C Deficiency–Associated VTE: Insights from Protein C Mutations C238G and R189W in Thai Patients	12
Obesity-Related Traits Mediate the Effects of Educational Attainment on the Risk of Varicose Veins, Venous Thromboembolism, and Phlebitis	12
Risk Factors for Bleeding in Cancer Patients Treated with Conventional Dose Followed by Low-Dose Apixaban for Venous Thromboembolism	12
	12
Unfavorably Altered Fibrin Clot Phenotype in Women Following Postpartum Hemorrhage of Unknown Cause: Effect of Lower Coagulation Factors	11
Ticagrelor Therapy Modifications after Acute Coronary Syndrome: An Ever-Evolving Issue	11
Trends in Acute Pulmonary Embolism Admission Rates and Mortality Outcomes in Australia, 2002–2003 to 2017–2018: A Retrospective Cohort Study	11
COVID-19 and Long-COVID Thrombosis: From Clinical and Basic Science to Therapeutics	11
	11
	11
Platelet Activation is Upregulated in Cirrhotic Patients with Portal Vein Thrombosis	11
Effectiveness and Safety of Apixaban versus Warfarin in Venous Thromboembolism Patients with Chronic Kidney Disease	11
Bleeding Propensity in Waldenström Macroglobulinemia: Potential Causes and Evaluation	11
Platelet-Derived TGF-β1 Promotes Deep Vein Thrombosis	11
Tissue Factor Pathway Inhibitor and Interleukin-1 Receptor Levels in COVID-19	11
Platelet-Released Extracellular Vesicle Characteristics Differ in Chronic and in Acute Heart Disease	11
Decreased Platelet Reactivity and Function in a Mouse Model of Human Pancreatic Cancer	11
Residual Venous Obstruction as an Indicator of Clinical Outcomes following Deep Vein Thrombosis: A Management Study	10
Hyperhomocysteinemia in Cardiovascular Diseases: Revisiting Observational Studies and Clinical Trials	10
Inflammatory Markers Differentiate Cerebral Venous Sinus Thrombosis from Mimics	10
TARGET: A Major European Project Aiming to Advance the Personalised Management of Atrial Fibrillation-Related Stroke via the Development of Health Virtual Twins Technology and Artificial Intelligence	10
Validation of Risk Assessment Models Predicting Venous Thromboembolism in Inpatients with Acute Exacerbation Of Chronic Obstructive Pulmonary Disease: A Multicenter Cohort Study in China	10
Anti-Galectin-2 Antibody Treatment Reduces Atherosclerotic Plaque Size and Alters Macrophage Polarity	10
Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation: Rationale and Design for PRESTIGE-AF Trial	10
Association between Clot Waveform Analysis Parameters and the Severity of Liver Cirrhosis	10
Oral Anticoagulation Timing in Patients with Acute Ischemic Stroke and Atrial Fibrillation	10
Estimating Bleeding Risk in Patients with Cancer-Associated Thrombosis: Evaluation of Existing Risk Scores and Development of a New Risk Score	10
Thrombosis and Haemostasis 2024 Editors' Choice Papers	10
Do Antiangiogenics Promote Clot Instability? Data from the TESEO Prospective Registry and Caravaggio Clinical Trial	10
Clinical and Genetic Characterization of 51 Patients with Congenital Fibrinogen Disorders from China	9
	9
Reply to “Commentary: ‘No Genetic Causality between Tobacco Smoking and Venous Thromboembolism: A Two-Sample Mendelian Randomization Study’ ”	9
Intraperitoneal Activation of Coagulation and Fibrinolysis in Patients with Cirrhosis and Ascites	9
The Hidden Culprit: Troubles with Enhanced Deglycosylation in Mechanical Circulatory Support	9
Iron-Driven Alterations on Red Blood Cell-Derived Microvesicles Amplify Coagulation during Hemolysis via the Intrinsic Tenase Complex	9
	9
Vaccine-Induced Thrombotic Thrombocytopenia: Insights from Blood Smear	9
Factor VIIa–Antithrombin Complexes are Increased in Asthma: Relation to the Exacerbation-Prone Asthma Phenotype	9
Commentary: “No Genetic Causality between Tobacco Smoking and Venous Thromboembolism: A Two-Sample Mendelian Randomization Study”	9
The Rise of the Machines: Using Machine Learning to Assess Thrombosis and Bleeding Risks, and Optimizing Anticoagulation Strategies	9
Small-Area Analysis of Treatment and Clinical Outcomes in Patients with Venous Thromboembolism in Denmark: A Nationwide Cohort Study	9
The Hard Bargain of Anticoagulation after Intracranial Hemorrhage, in the Setting of Venous Thromboembolism: Between a Rock and a Hard Place	9
Survival Implications of Thrombus Recurrence or Bleeding in Cancer Patients Receiving Anticoagulation for Venous Thromboembolism Treatment	9
Katacine Is a New Ligand of CLEC-2 that Acts as a Platelet Agonist	9
	9
Primary versus Secondary Immune Thrombocytopenia (ITP): A Meeting Report from the 2023 McMaster ITP Summit	9
COVID-19 Patients Putting on the Brakes with PAR1 Autoantibodies	9
Platelet Function and Maturity and Related microRNA Expression in Whole Blood in Patients with ST-Segment Elevation Myocardial Infarction	9
The Prognostic Performance of Rotational Thromboelastometry for Excessive Bleeding and Increased Transfusion Requirements in Hip Fracture Surgeries	9
New Inhibitors in the Ageing Population: A Retrospective, Observational, Cohort Study of New Inhibitors in Older People with Hemophilia	9
Incidence and Outcomes Associated with 6,841 Isolated Distal Deep Vein Thromboses in Patients with 13 Common Cancers	9
	9
Protein Phosphatase 1 γ Modulates Steady-State BAD Phosphorylation and Murine Platelet Survival	9
Modern Lung Scintigraphy Techniques for Optimizing the Diagnosis of Pulmonary Embolism: Great Expectations Still Awaiting to Be Met	8
Inverse Association of Lipoprotein(a) on Long-Term Bleeding Risk in Patients with Coronary Heart Disease: Insight from a Multicenter Cohort in Asia	8
Pathophysiology of Antiphospholipid Syndrome	8
Statin Treatment and the Alterations in the Platelet Lipidome: What Is the Impact of Lipid Profile on Thrombosis?	8
Sleep Apnea and Incident Unprovoked Venous Thromboembolism: Data from the Pays de la Loire Sleep Cohort	8
Proteomics in Thrombosis and Hemostasis	8
A Rollercoaster Plunge into 2022	8
	8
Risk of Ischemic Stroke in Asymptomatic Atrial Fibrillation Incidentally Detected in Primary Care Compared with Other Clinical Presentations	8
Decline in Overall Pulmonary Embolism-Related Mortality and Increasing Prevalence of Cancer-Associated Events in the Veneto Region (Italy), 2008–2019	8
Autoimmunity after Coronavirus Disease 2019 (COVID-19) Vaccine: A Case of Acquired Hemophilia A	8
A Trp11Arg Substitution in the β3 Signal Peptide Prevents Expression of αIIbβ3 in Patients with Glanzmann Thrombasthenia	8
Validation of the 2019 European Society of Cardiology Risk Stratification Algorithm for Pulmonary Embolism in Normotensive Elderly Patients	7
Hypercoagulability on Thromboelastography Can Predict the Functional Outcomes in Patients with Acute Ischemic Stroke	7
The Platelet Lipidome Is Altered in Patients with COVID-19 and Correlates with Platelet Reactivity	7
The Effect of Increasing Factor X Levels on Emicizumab-Driven Coagulation Potential	7
Visit-to-Visit Heart Rate Variability in the Prediction of Clinical Outcomes of Patients with Atrial Fibrillation	7
Coagulation Factor V (F5) is an Estrogen-Responsive Gene in Breast Cancer Cells	7

The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper	7
Endothelial Damage in JAK2V617F Myeloproliferative Neoplasms with Splanchnic Vein Thrombosis	7
Venous Thromboembolism in Women of Childbearing Age: Insights from the START Registry	7
Reflections on World Thrombosis Day 2024	7
Matrix Metalloproteinase-9 Levels are Associated with Brain Lesion and Persistent Venous Occlusion in Patients with Cerebral Venous Thrombosis	7
Aspirin for Primary and Secondary Prevention of Cardiovascular Disease: Time to Stop?	7
Role of Membrane Lipid Rafts in MRP4 (ABCC4) Dependent Regulation of the cAMP Pathway in Blood Platelets	7
Atrial Fibrillation Detected by Single Time-Point Handheld Electrocardiogram Screening and the Risk of Ischemic Stroke	7
Long-Term Safety of a Four-Factor Prothrombin Complex Concentrate (Kcentra®/Beriplex® P/N): An Updated Pharmacovigilance Review	7
Adventitial Vasa Vasorum Neovascularization in Femoral Artery of Type 2 Diabetic Patients with Macroangiopathy Is Associated with Macrophages and Lymphocytes as well as the Occurrence of Cardiovascula	7
Risk of Thromboembolic Events in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Meta-analysis of Randomized Controlled Trials	7
Reduced-Dose Intravenous Thrombolysis for Acute Intermediate–High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial	7
3-Factor versus 4-Factor Prothrombin Complex Concentrates for the Reversal of Vitamin K Antagonist-Associated Coagulopathy: A Systematic Review and Meta-analysis	7
More on the Source of D-Dimer in COVID-19	7
A Systematic Review of Economic Aspects of Service Interventions to Increase Anticoagulation Use in Atrial Fibrillation	7
Developing Validated Tools to Identify Pulmonary Embolism in Electronic Databases: Rationale and Design of the PE-EHR+ Study	6
Lack of Formyl-peptide Receptor 1 Mitigates Atherosclerosis in Hyperlipidemic Mice	6
	6
Strategies for Tailored Antiplatelet Therapy after Percutaneous Coronary Intervention: Unraveling Complexities, Embracing Nuances	6
Factor Xa Inhibitor Plasma Concentrations and Clinical Outcomes in Patients Weighing ≤50 kg—Experience from Four UK Centers	6
Cardiac Repair after Myocardial Infarction is Controlled by a Complement C5a Receptor 1-Driven Signaling Cascade	6
Severe SARS-CoV-2 Infection Inhibits Fibrinolysis Leading to Changes in Viscoelastic Properties of Blood Clot: A Descriptive Study of Fibrinolysis in COVID-19	6
The Role of Clot Waveform Analysis and Related Parameters in the Diagnosis and Treatment of Hemophilia A	6
	6
Timing of Off-Label Dosing of Direct Oral Anticoagulants in Three Large Health Systems	6
Gaining Insights into Inherited Bleeding Disorders of Complex Etiology in Pediatric Patients: Whole-Exome Sequencing as First-Line Investigation Tool	6
Patterns and Persistence of Anticoagulant Use in the Treatment of Venous Thromboembolism: Insights from South Korea	6
Reticulated Platelets: A Promising Prognosis Marker in Cardiovascular Diseases	6
A New Chapter Regarding Thrombosis Risk Assessment in Total Joint Replacement Patients	6
Low α-Thrombin/GPIbα Interaction Is a Potential Contributor to Platelet Hyper-reactivity in COVID-19 Patients	6
	6
Extracorporeal Membrane Oxygenation Induces Early Alterations in Coagulation and Fibrinolysis Profiles in COVID-19 Patients with Acute Respiratory Distress Syndrome	6
Carotid Stenosis and Stroke: Medicines, Stents, Surgery—“Wait-and-See” or Protect?	6
Enoxaparin for Long-Term Therapy of Venous Thromboembolism in Patients with Cancer and Renal Insufficiency	6
Dynamic Patterns and Persistence of Anticoagulation Therapy in Patients with Venous Thromboembolism in South Korea: A Nationwide Cohort Study	6
Guided Anti-P2Y12 Therapy in Patients Undergoing PCI: Three Systematic Reviews with Meta-analyses of Randomized Controlled Trials with Homogeneous Design	6
	6
Iron Macrophages: Dance of Death and MMP Release in Intraplaque Hemorrhage	6
Joint Effect of Multiple Prothrombotic Genotypes and Obesity on the Risk of Incident Venous Thromboembolism	6
Potential of Sulodexide in the Treatment of Diabetic Retinopathy and Retinal Vein Occlusion	6
The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation	6
Carbamylation Is Instrumental in End-Stage Kidney Disease Coagulopathies: The Impact on von Willebrand Factor and Platelet Functionality	5
Untargeted Plasma Metabolomics and Gut Microbiome Profiling Provide Novel Insights into the Regulation of Platelet Reactivity in Healthy Individuals	5
	5
Dynamics of Thrombogenicity and Platelet Function and Correlation with Bleeding Risk in Patients Undergoing M-TEER Using the PASCAL System	5
Risk of Bleeding in Liver Cirrhosis Receiving Direct Oral Anticoagulants: A Systematic Review and Meta-analysis	5
Circulating Blood Biomarkers and Risk of Venous Thromboembolism in Cancer Patients: A Systematic Review and Meta-Analysis	5
The Lipid–Platelet Interplay: Unraveling the Effects of PCSK9 Inhibition on Platelet Reactivity	5
Changes in Coagulation Factor XI Activity Levels in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary PCI	5
Final Analysis Results from the AGEHA Study: Emicizumab Prophylaxis for Acquired Hemophilia A with or without Immunosuppressive Therapy	5
Addendum: Sex as a Risk Factor for Atrial Fibrillation-Related Stroke	5
Machine Learning-Based Predictive Models for Patients with Venous Thromboembolism: A Systematic Review	5
Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper	5
Gene correction of Wiskott-Aldrich-syndrome iPS cells rescues proplatelet defects and improves platelet size.	5
Circulating Levels of Low-Density Granulocytes and Cell-Free DNA as Predictors of Cardiovascular Disease and Bone Deterioration in SLE Patients	5
Monocyte Subsets in Cardiovascular Disease: A Biomarker Perspective	5
Venous Thromboembolism Prophylaxis after Hematopoietic Cell Transplantation: Still a Challenge for Hematologists and Hemostasiologists	5
Linking Neutrophil Extracellular Traps and Platelet Activation: A Composite Biomarker Score for Predicting Outcomes after Acute Myocardial Infarction	5
Obesity and Pulmonary Embolism: Can We Dismantle the “Obesity Paradox”	5
Adherence to the ‘Atrial Fibrillation Better Care’ Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes—A Systematic Review and Meta-Analysis of 285,000 Patients	5
Ethnic Differences in Thrombotic Profiles of Acute Coronary Syndrome Patients and Relationship to Cardiovascular Outcomes: A Comparison of East Asian and White subjects	5
Clinical Implications of Discrepancy between One-Stage Clotting and Chromogenic Factor IX Activity in Hemophilia B	5
The Efficacy and Safety of DOACs in Inherited Antithrombin Deficiency: A Cohort Study from a Tertiary Referral Center	5
Characterization of CD3+ T Lymphocytes in Human Coronary Thrombi with ST-segment Elevation Myocardial Infarction	5
Exploring the Two-Way Link between Migraines and Venous Thromboembolism: A Bidirectional Two-Sample Mendelian Randomization Study	5
Dabigatran Attenuates the Binding of Thrombin to Platelets—A Novel Mechanism of Action	5
Transient Bacteremia Promotes Catheter-Related Central Venous Thrombosis through Neutrophil Extracellular Traps	5
	5
Associations between the von Willebrand Factor—ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality	5
The Story of the Fibrin(ogen) αC-Domains: Evolution of Our View on Their Structure and Interactions	5
Human Immunodeficiency Virus and Cardiovascular Disease: Revisiting the Inflammation–Thrombosis Axis	5
Monocyte Tissue Factor Expression: Lipopolysaccharide Induction and Roles in Pathological Activation of Coagulation	5
The Report of Community-Based and Government-Endorsed Screening Program of Atrial Fibrillation in Taiwan	5
Volume Regulation and Nonosmotic Volume of Individual Human Platelets Quantified by High-Speed Scanning Ion Conductance Microscopy	5
Venous Thromboembolism in Patients with Glioblastoma: Molecular Mechanisms and Clinical Implications	5
Treatment Modifications in Acute Coronary Syndrome Patients Treated with Ticagrelor: Insights from the FORCE-ACS Registry	5
Handheld Point-of-Care Devices for Snakebite Coagulopathy: A Scoping Review	4
Comparison of Apixaban and Aspirin in Preventing Portal Vein Thrombosis after Laparoscopic Splenectomy for Cirrhotic Hypersplenism	4
Mild COVID-19 and Impaired Blood Cell–Endothelial Crosstalk: Considering Long-Term Use of Antithrombotics?	4
Risk Factors of Cardiovascular Death after Venous Thromboembolism: Results from a Prospective Cohort Study	4
Single- and Multimarker Genome-Wide Scans Evidence Novel Genetic Risk Modifiers for Venous Thromboembolism	4
Changes in Endocan and Dermatan Sulfate Are Associated with Biomechanical Properties of Abdominal Aortic Wall during Aneurysm Expansion and Rupture	4
The Plasma Proteome and Risk of Future Venous Thromboembolism—Results from the HUNT Study	4
Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: Fraternal—Not Identical—Twins	4
Real-Life Management of Central and Branch Retinal Vein Occlusion: A Seven-Year Follow-Up Study	4
Do Patients with a Family or Personal History of Venous Thromboembolism have an Increased Risk of Recurrence?	4
Parenteral Antiplatelet Drugs in ST-Elevation Myocardial Infarction: Current Status and Future Directions	4
Balancing Risks and Benefits When Recommencing Oral Anticoagulants after Major Bleeding	4
Genetic Predisposition of Both Waist Circumference and Hip Circumference Increased the Risk of Venous Thromboembolism	4
Protein Tyrosine Phosphatase 1B Deficiency in Vascular Smooth Muscle Cells Promotes Perivascular Fibrosis following Arterial Injury	4
Pentosan Polysulfate Inhibits Attachment and Infection by SARS-CoV-2 In Vitro: Insights into Structural Requirements for Binding	4
Effectiveness and Safety of Oral Anticoagulants in the Treatment of Acute Venous Thromboembolism: A Nationwide Comparative Cohort Study in France	4
De-escalation of Prasugrel Results in Higher Percentage of Patients within Optimal Range of Platelet Reactivity: Analysis from the HOST-REDUCE-POLYTECH-ACS Trial	4
CircRNA circCOL1A1 Acts as a Sponge of miR-30a-5p to Promote Vascular Smooth Cell Phenotype Switch through Regulation of Smad1 Expression	4
	4